Biologic Effects of Tumor Necrosis Factors Alpha and Beta

  • Arthur J. Ammann
  • Michael A. PalladinoJr.
Part of the Contemporary Biomedicine book series (CB, volume 8)


As early as 1891, clinical reports suggested that major components of the cell wall of gram-negative bacteria such as endotoxins were associated with antitumor activities; Bruns (1) and Coley (2) described the regression of tumors in patients with tumors who were deliberately injected with mixtures of killed bacterial toxins. Gratia and Linz (3) and Shear et al. (4) subsequently demonstrated that bacterial filtrates or endotoxins were capable of inducing hemorrhagic necrosis of specific transplanted tumors. A significant advance in distinguishing the effects of endotoxin from a specific “tumor necrosis factor” was reported in 1975 by Carswell et al. (5). They were impressed with the observations and hypothesis of Algire (6), who suggested that hemorrhagic necrosis of tumors might be secondary to endotoxin-induced hypotension resulting in circulatory stasis and ischemia of the tumor. They argued, however, that rather than an indirect action, endotoxin probably caused the host to release a factor that was directly toxic to the tumor. This hypothesis led Carswell et al. (5) to the discovery of an endotoxin-induced serum factor, which caused necrosis of tumors and which they termed tumor necrosis factor (TNF-like).


Endotoxin Shock Intralesional Injection Hemorrhagic Necrosis Cord Blood Mononuclear Cell Recombinant Human Tumor Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bruns, P. Beitr. Z. Klin. Chir. 3, 433 (1888).Google Scholar
  2. 2.
    Coley, W. B. Ann. Surg. 14, 199 (1891).PubMedCrossRefGoogle Scholar
  3. 3.
    Gratia, A. and Linz, R. Scamces. Soc. Biol. Ses. Fil. 108, 427–428 (1931).Google Scholar
  4. 4.
    Shear, M. J. J. Natl. Cancer Inst. 4, 461–587 (1944).Google Scholar
  5. 5.
    Carswell, E. A., Old, L. J., Kassell, R. L., Green, S., Riore, N., and Williamson, B. Proc. Natl. Acad. Sci. USA 72, 3666–3670 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    Algire, G. H., Legallais, F. Y., and Kunii, O. Tohoku J. Exp. Med. 144, 385–396 (1984).CrossRefGoogle Scholar
  7. 7.
    Haranaka, K., Satomi, N., and Kunii, O. TohokuJ. Exp. Med. 144, 385–396 (1984).CrossRefGoogle Scholar
  8. 8.
    Niitusu, Y., Watanabe, N., Sone, H., Neda, H., and Uruushizakaki, I. Jpn. J. Cancer Res. 76, 395–399 (1985).Google Scholar
  9. 9.
    Neta, R., Salvin, S. B., and Sabaawi, M. Cell Immunol. 64, 203–219 (1981).PubMedCrossRefGoogle Scholar
  10. 10.
    Beutler, B. A., Milsark, I., and Cerami, A. J. Immunol. 135, 3972–3977 (1985).PubMedGoogle Scholar
  11. 11.
    Haranaka, K., Satomi, N., and Satomi, A. Int. J. Cancer 34, 263–267 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    Kahn, A., Martin, E. S., Webb, K., Weldon, D., Hill, N. O., Duvall, J., and Hill, J. M. Soc. Exp. Biol. Med. 169, 291–294 (1982).Google Scholar
  13. 13.
    Papermaster, B. W., Holterman, O. A., Klein, E., Dejerassi, I., Rosner, D., Dao, T., and Constanzi, J. J. Clin. Immunol. Immunopath. 5, 31–47 (1976).CrossRefGoogle Scholar
  14. 14.
    Fun, K. P., Leung, S. W., Ha, D. K. K., Ng, S. W., Choy, Y. M., and Lee, C. Y. Cancer Lett. 27, 269–276 (1985).CrossRefGoogle Scholar
  15. 15.
    Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., and Goeddel, D. V. Nature 312, 724–729 (1984).PubMedCrossRefGoogle Scholar
  16. 16.
    Talmadge, J. E., Tribble, H. R., Pennington, R. W., and Wiltrout, R. H., submitted (1986).Google Scholar
  17. 17.
    Philips, R. and Epstein, L. B. Nature 323, 86–89.Google Scholar
  18. 18.
    Urban, J. L., Shepard, H. M., Rothstein, J. L., Sugarman, B. J., and Schreiber, H., Proc. Natl. Acad. Sci. USA 83, 5233–5237 (1986).PubMedCrossRefGoogle Scholar
  19. 19.
    Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Palladino, M. A., and Shepard, H. M. Science 230, 943–945 (1985).PubMedCrossRefGoogle Scholar
  20. 20.
    Williamson, B. D., Carswell, E. A., Rubin, B. Y., Prendergasdt, J. S., and Old, L. J. Proc. Natl. Acad. Sci. USA 80, 5397–5401 (1983).PubMedCrossRefGoogle Scholar
  21. 21.
    Kawakami, M., Pekala, M., Lane, D., and Cerami, A. J. Exp. Med. 154, 631–639 (1981).PubMedCrossRefGoogle Scholar
  22. 22.
    Beutler, B., Mahoney, J., Trang, N. L., Pekla, P., and Cerami, A. J. Exp. Med. 161, 984–995 (1985).PubMedCrossRefGoogle Scholar
  23. 23.
    Beutler, B. A., Greenwald, D., and Hulmes, J. Nature 316, 552–554 (1985).PubMedCrossRefGoogle Scholar
  24. 24.
    Beutler, B. A. and Cerami, A. J. Immunol. 135, 3969–3971 (1985).PubMedGoogle Scholar
  25. 25.
    Keay, S. and Grossberg, S. E. Proc. Natl. Acad. Sci. USA 70, 4099–4103 (1980).CrossRefGoogle Scholar
  26. 26.
    Dixon, R. M., Bordon, E. C., Kein, H. L., Anderson, S., Spennelta, T. L., Tormey, D. C., and Shrago, E. Metabolism 33, 440–404 (1984).CrossRefGoogle Scholar
  27. 27.
    Satomi, N., Sakurai, A., and Haranaki, K. J. Natl. Cancer Inst. 74, 1255–1260 (1985).Google Scholar
  28. 28.
    Beutler, B. A., Milsark, L, and Cerami, A. Science 229, 869–871 (1985).PubMedCrossRefGoogle Scholar
  29. 29.
    Shalaby, M. R., Aggarwal, B. B., Rinderknecht, E., Svedersky, L. P., Finkle, B. S., and Palladino, M. A. J. Immunol. 135, 2069–2073 (1985).PubMedGoogle Scholar
  30. 30.
    Dayer, J. M., Beutler, B. A., and Cerami, A. J. Exp. Med. 162, 2163–2168 (1985).PubMedCrossRefGoogle Scholar
  31. 31.
    Gamble, J. R., Harlan, J. M., Klebanoff, S. J., and Vadas, V. A., Proc. Natl. Acad. Sci. USA 82, 8667–8671 (1986).CrossRefGoogle Scholar
  32. 32.
    Ammann, A. J., Palladino, M. A., Volberding, P., Abrams, D., Martin, N. L., Wert, R., and Conant, M., Clin. Lab. Immunol. (1987).Google Scholar
  33. 33.
    Chang, R. and Lee, S. H. TNO-ISR Meeting on the Interferon System 55 (1985).Google Scholar
  34. 34.
    Dayer, J. M., Beutler, B. A., and Cerami, A. J. Exp. Med. 162, 2163–2168 (1985).PubMedCrossRefGoogle Scholar
  35. 35.
    Collins, T., Lapierre, L. A., Fiers, W., Strominger, J. L., and Pober, J. S. Proc. Natl. Acad. Sci. USA 83(2), 446–450 (1986).PubMedCrossRefGoogle Scholar
  36. 36.
    Shalaby, M. R., Palladino, M. A., Hirabayashi, S. E., Eessalu, T. E., Lewis, G. D., Shepard, H. M., and Aggarwal, B. B. J. Immunol. 137, 2592–2598 (1986).PubMedGoogle Scholar
  37. 37.
    Lowry, R. P., Marghiesco, O. M., and Blackburn, J. H. Transplantation 40, 183–188 (1985).PubMedCrossRefGoogle Scholar
  38. 38.
    Johnson, R. L., Fink, C. W., and Ziff, M. J. Clin. Invest. 51, 2435–2449 (1972).PubMedCrossRefGoogle Scholar
  39. 39.
    Mirrakhimov, M. M., Kitaev, M. I., Imanbaev, A. S., and Markovich, M. O. Ter Arkh. 56, 53–56 (1985).Google Scholar
  40. 40.
    Aderka, D., Novick, D., Hahn, T., Fischer, D. G., and Wallach, D. Cell Immunol. 92, 218–225 (1985).PubMedCrossRefGoogle Scholar
  41. 41.
    Koff, W. C. and Fann, A. V. Lymphokin Res. 5, 215–221 (1986).Google Scholar
  42. 42.
    Taverne, J., Matthews, N., Depledge, P., and Playfair, H. L. Clin. Exp. Immunol. 57, 293–300 (1984).PubMedGoogle Scholar
  43. 43.
    Silberstein, D. S. and David, J. R. Proc. Natl. Acad. Sci. USA 83, 1055–1059 (1986).PubMedCrossRefGoogle Scholar
  44. 44.
    Eife, R. F., Eife, G., August, C. S., Kuhre, W. L., and Staehr-Johansen, K. Cell Immunol. 14, 435–442 (1974).PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc. 1988

Authors and Affiliations

  • Arthur J. Ammann
  • Michael A. PalladinoJr.

There are no affiliations available

Personalised recommendations